Gene Therapy and Cell Therapy in Personalized Medicine
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Methodology, Drug and Device Discovery".
Deadline for manuscript submissions: closed (5 March 2024) | Viewed by 83
Special Issue Editors
2. Department of Medical-Surgical Science and Advanced Technologies "Ingrassia", University of Catania, 95123 Catania, Italy
Interests: epigenetics; metabolism; tumor microenvironment; inflammation
Interests: tumor microenvironment; metabolism; cancer; metabolic reprogramming; Warburg effect; lactate
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The aim of this Special Issue, titled “Gene Therapy and Cell Therapy in Personalized Medicine”, is to focus on the usage of personalized medicine in clinics. In particular, we aim to address the need for improving gene and cell therapy in this context. This Special Issue will therefore assess the potential of these techniques in improving the current standard treatments, and thus the patients’ lifespan, modulating the disease course without providing an efficient cure. Therefore, (i) delivering genetic material in locus, by using specific vectors, acting on the genetic level; and/or (ii) using cells to treat different diseases at the cellular level, for instance, by using induced pluripotent stem cells. This might pave the way the development of novel personalized therapies.
Dr. Sebastiano Giallongo
Dr. Lucia Longhitano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized therapy
- cell therapy
- gene therapy
- epigenetics
- drug delivery vectors
- stem cells
- induced pluripotent stem cells
